Stefania Butini

5.4k total citations
140 papers, 3.5k citations indexed

About

Stefania Butini is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Stefania Butini has authored 140 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 47 papers in Organic Chemistry and 23 papers in Pharmacology. Recurrent topics in Stefania Butini's work include HIV/AIDS drug development and treatment (18 papers), Computational Drug Discovery Methods (16 papers) and Malaria Research and Control (15 papers). Stefania Butini is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), Computational Drug Discovery Methods (16 papers) and Malaria Research and Control (15 papers). Stefania Butini collaborates with scholars based in Italy, Ireland and United States. Stefania Butini's co-authors include Giuseppe Campiani, Sandra Gemma, Margherita Brindisi, Simone Brogi, Ettore Novellino, Caterina Fattorusso, Vito Nacci, Luisa Savini, Giulia Chemi and Nicola Relitti and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

In The Last Decade

Stefania Butini

136 papers receiving 3.5k citations

Peers

Stefania Butini
Stefania Butini
Citations per year, relative to Stefania Butini Stefania Butini (= 1×) peers Sandra Gemma

Countries citing papers authored by Stefania Butini

Since Specialization
Citations

This map shows the geographic impact of Stefania Butini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Butini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Butini more than expected).

Fields of papers citing papers by Stefania Butini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Butini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Butini. The network helps show where Stefania Butini may publish in the future.

Co-authorship network of co-authors of Stefania Butini

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Butini. A scholar is included among the top collaborators of Stefania Butini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Butini. Stefania Butini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fedeli, Riccardo, Maria Dichiara, Gabriele Carullo, et al.. (2024). Unlocking the potential of biostimulants in sustainable agriculture: Effect of wood distillate on the nutritional profiling of apples. Heliyon. 10(18). e37599–e37599. 4 indexed citations
3.
Fedeli, Riccardo, Luca Frattaruolo, Gabriele Carullo, et al.. (2023). Nutritionally enriched tomatoes ( Solanum lycopersicum L.) grown with wood distillate: chemical and biological characterization for quality assessment. Journal of Food Science. 88(12). 5324–5338. 17 indexed citations
4.
Gemma, Sandra, Sarah Mazzotta, Gabriele Carullo, et al.. (2023). Synthetic derivatives of natural cinnamic acids as potential anti‐colorectal cancer agents. Chemical Biology & Drug Design. 103(1). e14415–e14415. 4 indexed citations
5.
Contri, Chiara, Silvia Pasquini, Gabriele Carullo, et al.. (2023). Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents. Archiv der Pharmazie. 356(12). e2300410–e2300410. 4 indexed citations
6.
Carullo, Gabriele, Giovanni Di Bonaventura, Sara Rossi, et al.. (2023). Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains. Molecules. 28(18). 6535–6535. 7 indexed citations
7.
Bergantini, Laura, Miriana d’Alessandro, Giuseppe Campiani, et al.. (2022). Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis. Cells. 11(9). 1441–1441. 3 indexed citations
8.
Battista, Theo, Stefano Federico, Simone Brogi, et al.. (2022). Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach. ACS Infectious Diseases. 8(8). 1687–1699. 7 indexed citations
9.
Saccoccia, Fulvio, Stefania Butini, Alessandra Guidi, et al.. (2022). Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors. Journal of Biological Chemistry. 298(10). 102375–102375. 6 indexed citations
10.
Relitti, Nicola, Stefano Federico, Stefania Butini, et al.. (2021). Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity. European Journal of Medicinal Chemistry. 215. 113227–113227. 5 indexed citations
11.
Janssen, Antonius P. A., et al.. (2018). Development of a Multiplexed Activity-Based Protein Profiling Assay to Evaluate Activity of Endocannabinoid Hydrolase Inhibitors. ACS Chemical Biology. 13(9). 2406–2413. 29 indexed citations
12.
Chemi, Giulia, Sandra Gemma, Giuseppe Campiani, et al.. (2017). Computational Tool for Fast in silico Evaluation of hERG K+ Channel Affinity. Frontiers in Chemistry. 5. 7–7. 51 indexed citations
13.
Khanfar, Mohammad A., et al.. (2016). Multiple Targeting Approaches on Histamine H3 Receptor Antagonists. Frontiers in Neuroscience. 10. 201–201. 42 indexed citations
14.
Chioua, Mourad, Marta Pérez, Óscar M. Bautista‐Aguilera, et al.. (2015). Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease. Mini-Reviews in Medicinal Chemistry. 15(8). 648–658. 10 indexed citations
15.
Brogi, Simone, Stefania Butini, Samuele Maramai, et al.. (2014). Disease‐Modifying Anti‐Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β‐Amyloid Aggregation. CNS Neuroscience & Therapeutics. 20(7). 624–632. 46 indexed citations
16.
Gemma, Sandra, Simone Brogi, Ettore Novellino, et al.. (2014). HCV-targeted Antivirals: Current Status and Future Challenges. Current Pharmaceutical Design. 20(21). 3445–3464. 7 indexed citations
17.
Brindisi, Margherita, Stefania Butini, Simone Brogi, et al.. (2014). Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies. Journal of Medicinal Chemistry. 57(22). 9578–9597. 40 indexed citations
18.
Butini, Stefania, Margherita Brindisi, Simone Brogi, et al.. (2013). Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation. ACS Medicinal Chemistry Letters. 4(12). 1178–1182. 39 indexed citations
19.
Greene, Lisa M., Siobhan McGuckin, Paul Browne, et al.. (2009). The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia. Cancer Research. 69(21). 8366–8375. 30 indexed citations
20.
Budriesi, Roberta, Pierfranco Ioan, Alberto Chiarini, et al.. (2004). Development of Potent and Selective Peripheral 5-HT3 Receptor Agonists and Antagonists, Keystones of a New Therapeutic Strategy to Cardiac Diseases. Fundamental and Clinical Pharmacology. 18. 138–138. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026